Grainger, Rebecca
Kim, Alfred H. J. http://orcid.org/0000-0003-4074-0516
Conway, Richard
Yazdany, Jinoos http://orcid.org/0000-0002-3508-4094
Robinson, Philip C. http://orcid.org/0000-0002-3156-3418
Article History
Accepted: 28 January 2022
First Online: 25 February 2022
Competing interests
: R.G. reports receiving speakers bureau honoraria from AbbVie, Cornerstones and Janssen, consulting fees from AstraZeneca and Novartis, and non-financial support from Janssen and Pfizer. A.H.J.K. reports receiving research grant funding from GlaxoSmithKline, consulting fees from Alexion Pharmaceuticals, Aurinia Pharmaceuticals, Exagen Diagnostics and GlaxoSmithKline, and speakers bureau honoraria from Aurinia Pharmaceuticals, Exagen Diagnostics and GlaxoSmithKline. R.C. reports receiving speakers bureau honoraria from AbbVie, Janssen, Roche and Sanofi. J.Y. reports receiving research grant funding from AstraZeneca and Gilead and consulting fees from AstraZeneca, Aurinia, Eli Lilly and Pfizer. P.C.R. reports receiving personal fees from AbbVie, Atom Biosciences, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, Roche and UCB, meeting-attendance support from Bristol Myers Squibb, Pfizer and UCB, and grant funding from Janssen, Novartis, Pfizer and UCB.
Free to read: This content has been made available to all.